SCHEMBL2908244

SCHEMBL2908244

O=C1c2cc(Cl)c(Cl)cc2C(=O)c2c1c(O)c1ccccc1c2O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.47
MAPT P10636 5/20 0.47
KMT2A Q03164 5/20 0.47
KDM4E B2RXH2 4/20 0.47
MAOA P21397 4/20 0.47
ALDH1A1 P00352 3/20 0.47
HPGD P15428 3/20 0.47
HSD17B10 Q99714 3/20 0.47
RECQL P46063 3/20 0.47
TTR P02766 2/20 0.47
CYP3A4 P08684 2/20 0.47
ALOX15 P16050 2/20 0.47
ALOX12 P18054 2/20 0.47
MAPK1 P28482 2/20 0.47
DAPK1 P53355 2/20 0.47
CYP1B1 Q16678 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
CYP1A1 P04798 2/20 0.47
HSPD1 P10809 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13210193 0.88 CYP1A1 (0.43) MEN1MAPTKMT2AKDM4EMAOA
SCHEMBL9133388 0.86 ALDH1A1 (0.38) MEN1MAPTKMT2AKDM4EMAOA
SCHEMBL9296456 0.85 MEN1 (0.56) MEN1MAPTKMT2AKDM4EMAOA
SCHEMBL9493981 0.84 S100A4 (0.59) MEN1MAPTKMT2AKDM4EMAOA
SCHEMBL29883673 0.81 MEN1 (0.61) MEN1MAPTKMT2AKDM4EMAOA
SCHEMBL497005 0.81 MEN1 (0.61) MEN1MAPTKMT2AKDM4EMAOA
SCHEMBL4835973 0.79 MAPT (0.50) MEN1MAPTKMT2AKDM4EMAOA
SCHEMBL2901286 0.78 HSD17B10 (0.53) MEN1MAPTKMT2AKDM4EMAOA
SCHEMBL13568733 0.77 MEN1 (0.43) MEN1MAPTKMT2AKDM4EMAOA
SCHEMBL13568743 0.77 PGAM1 (0.45) MEN1MAPTKMT2AKDM4EMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9039946-B2 Reversibly thermochromic compositions BASF SE (DE) 2015-05-26 US disclosed
US-9039946-B2 Reversibly thermochromic compositions BASF SE (DE) 2015-05-26 US disclosed
US-9039946-B2 Reversibly thermochromic compositions BASF SE (DE) 2015-05-26 US disclosed
EP-1888705-B1 Reversibly thermochromic compositions BASF SE (DE) 2010-08-18 EP disclosed
EP-1888705-B1 Reversibly thermochromic compositions BASF SE (DE) 2010-08-18 EP disclosed
US-20090302284-A1 Reversibly Thermochromic Compositions CIBA CORPORATION 2009-12-10 US disclosed
US-20090302284-A1 Reversibly Thermochromic Compositions CIBA CORPORATION 2009-12-10 US disclosed
US-20090302284-A1 Reversibly Thermochromic Compositions CIBA CORPORATION 2009-12-10 US disclosed
EP-1888705-A1 REVERSIBLY THERMOCHROMIC COMPOSITIONS Ciba Specialty Chemicals Holding, Inc. (CH) 2008-02-20 EP disclosed
WO-2006131465-A1 REVERSIBLY THERMOCHROMIC COMPOSITIONS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2006-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090302284-A1 Reversibly Thermochromic Compositions DHCR7, NES, DUT MEN1 946/4885MAPT 1138/4885KMT2A 1932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.